Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Case Report
Author Details :
Volume : 6, Issue : 4, Year : 2020
Article Page : 650-653
https://doi.org/10.18231/j.ijceo.2020.138
Abstract
A 15 years old girl presented to us with diminution of vision within 4 days of onset. The child underwent relevant investigations and a diagnosis of optic disc pit maculopathy (OPD-M) was made. The parents refused surgical intervention and so we started the child on oral acetazolamide. She was kept under repeated and close follow-ups. We noticed rapid resolution of optic disc pit maculopathy within 2 months of presentation with complete visual recovery. Oral acetazolamide was tapered during the course of 2 months. We conclude that although numerous treatment modalities have been described for optic disc pit maculopathy, a trial of oral acetazolamide can be offered in cases of optic disc pit maculopathy in paediatric patients.
Keywords: Acetazolamide, Optic disc pit maculopathy, Paediatric patient.
How to cite : Mehta R A , Mehta N R , Mehta S , Mehta A , Acetazolamide assisted rapid resolution of optic disc pit maculopathy in a 15 year old child. Indian J Clin Exp Ophthalmol 2020;6(4):650-653
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
